Repurposing N,N-dimethylacetamide (DMA), a pharmaceutical excipient, as a prototype novel anti-inflammatory agent for the prevention and/or treatment of preterm birth

Medicine & Life Sciences

• dimethylacetamide 100%
• Excipients 65%
• Premature Birth 59%
• Anti-Inflammatory Agents 41%
• Pharmaceutical Preparations 23%
• Inflammation 14%
• Parturition 11%
• Drug Therapy 9%
• Perinatal Mortality 9%
• Therapeutics 9%
• NF-kappa B 8%
• Lipopolysaccharides 6%
• Cytokines 4%
• Pregnancy 4%
• Morbidity 4%
• In Vitro Techniques 3%

Chemical Compounds

• Anti-Inflammatory Agent 71%
• N,N-Dimethylacetamide 66%
• Lipopolysaccharide 61%
• Excipient 61%
• Pharmaceutical 41%
• Solvent 26%